News
SFOSF
2.500
-10.07%
-0.280
Fosun Pharma Subsidiary Launches Phase I Trial of PSMA Radiopharmaceutical for Advanced Prostate Cancer
TipRanks · 12/30/2025 11:39
Weekly Report: what happened at SFOSF last week (1222-1226)?
Weekly Report · 12/29/2025 09:51
Weekly Report: what happened at SFOSF last week (1215-1219)?
Weekly Report · 12/22/2025 09:51
Weekly Report: what happened at SFOSF last week (1208-1212)?
Weekly Report · 12/15/2025 09:56
Shanghai Fosun Pharmaceutical (Group) Co (SFOSF) Gets a Buy from CSC Financial
TipRanks · 12/13/2025 00:25
Fosun Pharma Subsidiary Gains Approval for Ketoprofen Patch Clinical Trials
TipRanks · 12/12/2025 12:08
CLSA Reaffirms Their Buy Rating on Shanghai Fosun Pharmaceutical (Group) Co (SFOSF)
TipRanks · 12/12/2025 00:25
Fosun Pharma’s Subsidiary Gains Approval for New Drug
TipRanks · 12/10/2025 10:38
Pfizer in pact with China’s Fosun Pharma for oral GLP-1 drugs
Seeking Alpha · 12/09/2025 15:10
Weekly Report: what happened at SFOSF last week (1201-1205)?
Weekly Report · 12/08/2025 09:55
Fosun Pharma Subsidiary Gains Approval for Innovative Cancer Drug Trial
TipRanks · 12/03/2025 10:08
Fosun Pharma’s Subsidiary Gains Approval for Heparin Sodium Injection
TipRanks · 12/02/2025 13:07
Shanghai Fosun Pharmaceutical Announces EGM Results and Director Election
TipRanks · 12/02/2025 12:10
Shanghai Fosun Pharmaceutical Announces Board Composition and Committee Roles
TipRanks · 12/02/2025 12:09
Weekly Report: what happened at SFOSF last week (1124-1128)?
Weekly Report · 12/01/2025 09:52
Fosun Pharma Announces Strategic Agreements with CQ Pharma and Fosun International
TipRanks · 11/28/2025 12:45
Weekly Report: what happened at SFOSF last week (1117-1121)?
Weekly Report · 11/24/2025 09:55
Fosun Pharma’s Pediatric Drug Application Gains Priority Review
TipRanks · 11/21/2025 10:12
Fosun Pharma’s Subsidiary Gains Approval for New Drug Application
TipRanks · 11/18/2025 10:09
Weekly Report: what happened at SFOSF last week (1110-1114)?
Weekly Report · 11/17/2025 09:55
More
Webull provides a variety of real-time SFOSF stock news. You can receive the latest news about Shanghai Fosun Pharmaceutical through multiple platforms. This information may help you make smarter investment decisions.
About SFOSF
Shanghai Fosun Pharmaceutical Group Co Ltd is a China-based company mainly engaged in the research and development, manufacturing and sales of pharmaceutical products. The Company operates in five segments. Pharmaceutical segment is mainly engaged in the manufacturing of innovative drugs, mature pharmaceutical products and vaccines. Medical Devices and Medical Diagnostics segment is mainly engaged in the manufacturing and sales of medical cosmetic devices such as molecular diagnosis, immunodiagnosis, and microbial diagnosis. Medical Health Services segment is mainly engaged in the operation of an online and offline integrated medical service platform. Pharmaceutical Distribution and Retail segment is mainly engaged in the wholesale and retail of pharmaceutical products. Others segment is engaged in other pharmaceutical-related businesses. The Company's products are mainly used in the treatment of tumors, immunity, central nervous system and other fields.